SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 8th, 2017 • PAVmed Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledAugust 8th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 4, 2017, between PAVmed Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 8th, 2017 • PAVmed Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 8th, 2017 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of August 4, 2017, by and among PAVmed Inc., a Delaware corporation, with headquarters located at One Grand Central Place, Suite 4600, New York, New York 10165 (the “Company”), and the undersigned purchasers (each, a “Purchaser”, and collectively, the “Purchasers”).
SERIES A-1 COMMON STOCK PURCHASE WARRANT PAVMED inc.Common Stock Purchase Warrant • August 8th, 2017 • PAVmed Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledAugust 8th, 2017 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time after the date the stockholder approval referred to in Section 2 has been obtained and is effective (the “Initial Exercise Date”) and on or prior to the close of business on April 30, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from PAVmed Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock or to exchange this Warrant for Series X Warrants in the form attached as Exhibit A (the “Series X Warrants”) (the Series X Warrants, collectively, the “Exchange Warrants”) as set forth in Section 3. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section